Global Biological Data Visualization Market is expected to reach US$ 1.71 Bn. at a CAGR of 9.8% during the forecast period 2023-2029.Biological Data Visualization Market Overview:
The biological data visualization sector is swiftly growing. Image-processing combined with artificial intelligence-based pattern recognition, new programming language, & innovative libraries for visual analytics have seen notable advances in recent years. Moreover, the start of virtual reality environment is anticipated to transform the market development as it lets the integration of biological data in virtual worlds.To know about the Research Methodology :- Request Free Sample Report Rapid growth in the sector of big data along with large size & complexity of biological data has caused improved utilization of visualization tools globally. Moreover, rising demand for decisions to be made in a reduced time needs radical analytical tools. These tools support in deriving extensive data from larger chunks of unorganized data in a small period of time. These aspects are expected to drive the acceptance rate of visualizing tools during the forecast period. The analysis of relationships between biological networks & molecules has become a key bottleneck in systems biology. In order to fight this concern, some conferences are presented to showcase the significance of visualizations in systems biology, which rises the adoption of these tools among the researchers. The Visualizing Biological Data workshop, held in Germany in the year 2022, signified that data visualization can possibly drive progressions in molecular & systems biology. The expanded horizon of artificial intelligence in big data analysis hurries the adoption rate of computational visualizing tools in biomedical study. As compared to traditional approaches, machine learning-based approaches are more consistent, robust, & accurate. Besides, with the rise of developed computing & storage capabilities, the analysis level for biological data has moved to a molecular level from sequence-based level, which in turn, aids the biomedical research. Recently, biological data mining is gradually getting combined with biological & medical discovery processes. This has caused the generation of large amounts of genomic & proteomic datasets. The incredible growth in data mining added to the employment of visualization tools for the study of genomic data, thereby accelerating market development. Academic research is projected to be the largest end-use segment in the 2022 & is projected to further increase during the forecast period. The wide usage of sequencing & MRI methodologies in biomedical investigation, on-site bioinformatics developments, & workshops donate to the assessed share. Ongoing partnerships between research entities & firms for the growth of visualization tools & supporting the researchers are causing a larger share.For example, in October 2021, Plotly & McGill University entered into a partnership for the finance for new interns. Plotly is working together with a not-for-profit group, Mitacs, to offer financial support to interns & also supports the use of Plotly’s Dash software for data investigation & visualization. This enhanced the analysis of nervous disorders in researchers North America accounted for the largest share in terms of revenue generation in the year 2022. The development of capital-intensive biotechnology sectors, like personalized medicine & the development of high-throughput sequencing techniques, add to the larger share. High research & development investment in the region surely impacts the progress of these sectors, accelerating the demand for study software to visualize the biological data produced or required for these sector. The Asia Pacific region accounted for a highly productive growth rate owing to major developments started by public agencies to support the utilization of big data & data science in this region. The market is compelled by the strategic initiatives adopted by regional contributors to reinforce their market occurrence in local & global markets. For example, in July 2022, a Japan-based company, Olympus Corporation introduced scanR 3.1 High-content Screening Station (HCS) which employs AI for the analysis of live cells, therefore helping the company’s sales.
Competitive Landscape:
The objective of the report is to present a comprehensive analysis of the Global Biological Data Visualization Market including all the stakeholders of the industry. The past and current status of the industry with forecasted Market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes Market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the Market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Biological Data Visualization Market dynamics, structure by analyzing the Market segments and project the Global Biological Data Visualization Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Raw material portfolio, growth strategies, and regional presence in the Global Biological Data Visualization Market make the report investor’s guide.Scope of Global Biological Data Visualization Market: Inquire before buying
Biological Data Visualization Market Base Year 2022 Forecast Period 2023-2029 Historical Data CAGR Market Size in 2022 Market Size in 2029 2018 to 2022 9.8% US$ 0.88 Bn US$ 1.71 Bn Segments Covered by Technique Microscopy Magnetic Resonance Imaging Sequencing X-ray Crystallography Others by Platform Windows Mac OS Linux Others by End Use Academic Research Hospitals & Clinics Pharmaceutical & Biotechnology Companies Other Users Regions Covered North America United States Canada Mexico Europe UK France Germany Italy Spain Sweden Austria Rest of Europe Asia Pacific China S Korea Japan India Australia Indonesia Malaysia Vietnam Taiwan Bangladesh Pakistan Rest of APAC Middle East and Africa South Africa GCC Egypt Nigeria Rest of ME&A South America Brazil Argentina Rest of South America Biological Data Visualization Market Key Players are:
1. Thermo Fisher Scientific Inc. 2. QIAGEN 3. Becton-Dickinson and Company 4. Agilent Technologies, Inc. 5. 3M 6. Carl Zeiss AG 7. Oxford Instruments 8. Olympus Corporation 9. GE Healthcare 10. Clarivate Analytics 11. arivis AG 12. Scientific Volume Imaging B.V. 13. Media Cybernetics, Inc. 14. Molecular Devices, LLC 15. Danaher Frequently Asked questions 1. What is the market size of the Global Biological Data Visualization Market in 2022? Ans. The market size Global Biological Data Visualization Market in 2022 was US$ 0.88 Billion. 2. What are the different segments of the Global Biological Data Visualization Market ? Ans. The Global Biological Data Visualization Market is divided into Technique, Platform and End Use. 3. What is the study period of this market? Ans. The Global Biological Data Visualization Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Biological Data Visualization Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Biological Data Visualization Market ? Ans. The Forecast Period of the market is 2023-2029 in the market.
Global Biological Data Visualization Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Biological Data Visualization Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Biological Data Visualization Market Analysis and Forecast 7. Global Biological Data Visualization Market Analysis and Forecast, by Technique 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Biological Data Visualization Market Value Share Analysis, by Technique 7.4. Global Biological Data Visualization Market Size (US$ Mn) Forecast, by Technique 7.5. Global Biological Data Visualization Market Analysis, by Technique 7.6. Global Biological Data Visualization Market Attractiveness Analysis, by Technique 8. Global Biological Data Visualization Market Analysis and Forecast, by Platform 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Biological Data Visualization Market Value Share Analysis, by Platform 8.4. Global Biological Data Visualization Market Size (US$ Mn) Forecast, by Platform 8.5. Global Biological Data Visualization Market Analysis, by Platform 8.6. Global Biological Data Visualization Market Attractiveness Analysis, by Platform 9. Global Biological Data Visualization Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Biological Data Visualization Market Value Share Analysis, by End User 9.4. Global Biological Data Visualization Market Size (US$ Mn) Forecast, by End User 9.5. Global Biological Data Visualization Market Analysis, by End User 9.6. Global Biological Data Visualization Market Attractiveness Analysis, by End User 10. Global Biological Data Visualization Market Analysis and Forecast, by Region 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Biological Data Visualization Market Value Share Analysis, by Region 10.4. Global Biological Data Visualization Market Size (US$ Mn) Forecast, by Region 10.5. Global Biological Data Visualization Market Analysis, by Region 11. Global Biological Data Visualization Market Analysis 11.1. Key Findings 11.2. Global Biological Data Visualization Market Overview 11.3. Global Biological Data Visualization Market Forecast, by Technique 11.3.1. Microscopy 11.3.2. Magnetic Resonance Imaging 11.3.3. Sequencing 11.3.4. X-ray Crystallography 11.3.5. Others 11.4. Global Biological Data Visualization Market Forecast, by Platform 11.4.1. Windows 11.4.2. Mac OS 11.4.3. Linux 11.4.4. Others 11.5. Global Biological Data Visualization Market Forecast, by End User 11.5.1. Academic Research 11.5.2. Hospitals & Clinics 11.5.3. Pharmaceutical & Biotechnology Companies 11.5.4. Other Users 11.6. Global Biological Data Visualization Market Forecast, by Region 11.6.1. North America 11.6.2. Europe 11.6.3. Asia-Pacific 11.6.4. MEA & Africa 11.6.5. Latin America 11.7. PEST Analysis 11.8. Key Trends 11.9. Key Developments 12. North-America Biological Data Visualization Market Analysis 12.1. Key Findings 12.2. North America Biological Data Visualization Market Forecast, by Technique 12.2.1. Microscopy 12.2.2. Magnetic Resonance Imaging 12.2.3. Sequencing 12.2.4. X-ray Crystallography 12.2.5. Others 12.3. North America Biological Data Visualization Market Forecast, by Platform 12.3.1. Windows 12.3.2. Mac OS 12.3.3. Linux 12.3.4. Others 12.4. North America Biological Data Visualization Market Forecast, by End User 12.4.1. Academic Research 12.4.2. Hospitals & Clinics 12.4.3. Pharmaceutical & Biotechnology Companies 12.4.4. Other Users 12.5. North-America Biological Data Visualization Market Forecast, by Country 12.5.1. US 12.5.2. Canada 12.6. US Biological Data Visualization Market Forecast, by Technique 12.6.1. Microscopy 12.6.2. Magnetic Resonance Imaging 12.6.3. Sequencing 12.6.4. X-ray Crystallography 12.6.5. Others 12.7. US Biological Data Visualization Market Forecast, by Platform 12.7.1. Windows 12.7.2. Mac OS 12.7.3. Linux 12.7.4. Others 12.8. US Biological Data Visualization Market Forecast, by End User 12.8.1. Academic Research 12.8.2. Hospitals & Clinics 12.8.3. Pharmaceutical & Biotechnology Companies 12.8.4. Other Users 12.9. Canada Biological Data Visualization Market Forecast, by Technique 12.9.1. Microscopy 12.9.2. Magnetic Resonance Imaging 12.9.3. Sequencing 12.9.4. X-ray Crystallography 12.9.5. Others 12.10. Canada Biological Data Visualization Market Forecast, by Platform 12.10.1. Windows 12.10.2. Mac OS 12.10.3. Linux 12.10.4. Others 12.11. Canada Biological Data Visualization Market Forecast, by End User 12.11.1. Academic Research 12.11.2. Hospitals & Clinics 12.11.3. Pharmaceutical & Biotechnology Companies 12.11.4. Other Users 12.12. PEST Analysis 12.13. Key Trends 12.14. Key Developments 13. Europe Biological Data Visualization Market Analysis 13.1. Key Findings 13.2. Europe Biological Data Visualization Market Overview 13.3. Europe Biological Data Visualization Market Forecast, by Technique 13.3.1. Microscopy 13.3.2. Magnetic Resonance Imaging 13.3.3. Sequencing 13.3.4. X-ray Crystallography 13.3.5. Others 13.4. Europe Biological Data Visualization Market Forecast, by Platform 13.4.1. Windows 13.4.2. Mac OS 13.4.3. Linux 13.4.4. Others 13.5. Europe Biological Data Visualization Market Forecast, by End User 13.5.1. Academic Research 13.5.2. Hospitals & Clinics 13.5.3. Pharmaceutical & Biotechnology Companies 13.5.4. Other Users 13.6. Europe Biological Data Visualization Market Forecast, by Country 13.6.1. UK 13.6.2. France 13.6.3. Germany 13.6.4. Russia 13.6.5. Italy 13.6.6. Rest of Europe 13.7. UK Biological Data Visualization Market Forecast, by Technique 13.7.1. Microscopy 13.7.2. Magnetic Resonance Imaging 13.7.3. Sequencing 13.7.4. X-ray Crystallography 13.7.5. Others 13.8. UK Biological Data Visualization Market Forecast, by Platform 13.8.1. Windows 13.8.2. Mac OS 13.8.3. Linux 13.8.4. Others 13.9. UK Biological Data Visualization Market Forecast, by End User 13.9.1. Academic Research 13.9.2. Hospitals & Clinics 13.9.3. Pharmaceutical & Biotechnology Companies 13.9.4. Other Users 13.10. France Biological Data Visualization Market Forecast, by Technique 13.10.1. Microscopy 13.10.2. Magnetic Resonance Imaging 13.10.3. Sequencing 13.10.4. X-ray Crystallography 13.10.5. Others 13.11. France Biological Data Visualization Market Forecast, by Platform 13.11.1. Windows 13.11.2. Mac OS 13.11.3. Linux 13.11.4. Others 13.12. France Biological Data Visualization Market Forecast, by End User 13.12.1. Academic Research 13.12.2. Hospitals & Clinics 13.12.3. Pharmaceutical & Biotechnology Companies 13.12.4. Other Users 13.13. Germany Biological Data Visualization Market Forecast, by Technique 13.13.1. Microscopy 13.13.2. Magnetic Resonance Imaging 13.13.3. Sequencing 13.13.4. X-ray Crystallography 13.13.5. Others 13.14. Germany Biological Data Visualization Market Forecast, by Platform 13.14.1. Windows 13.14.2. Mac OS 13.14.3. Linux 13.14.4. Others 13.15. Germany Biological Data Visualization Market Forecast, by End User 13.15.1. Academic Research 13.15.2. Hospitals & Clinics 13.15.3. Pharmaceutical & Biotechnology Companies 13.15.4. Other Users 13.16. Russia Biological Data Visualization Market Forecast, by Technique 13.16.1. Microscopy 13.16.2. Magnetic Resonance Imaging 13.16.3. Sequencing 13.16.4. X-ray Crystallography 13.16.5. Others 13.17. Russia Biological Data Visualization Market Forecast, by Platform 13.17.1. Windows 13.17.2. Mac OS 13.17.3. Linux 13.17.4. Others 13.18. Russia Biological Data Visualization Market Forecast, by End User 13.18.1. Academic Research 13.18.2. Hospitals & Clinics 13.18.3. Pharmaceutical & Biotechnology Companies 13.18.4. Other Users 13.19. Italy Biological Data Visualization Market Forecast, by Technique 13.19.1. Microscopy 13.19.2. Magnetic Resonance Imaging 13.19.3. Sequencing 13.19.4. X-ray Crystallography 13.19.5. Others 13.20. Italy Biological Data Visualization Market Forecast, by Platform 13.20.1. Windows 13.20.2. Mac OS 13.20.3. Linux 13.20.4. Others 13.21. Italy Biological Data Visualization Market Forecast, by End User 13.21.1. Academic Research 13.21.2. Hospitals & Clinics 13.21.3. Pharmaceutical & Biotechnology Companies 13.21.4. Other Users 13.22. Rest of Europe Biological Data Visualization Market Forecast, by Technique 13.22.1. Microscopy 13.22.2. Magnetic Resonance Imaging 13.22.3. Sequencing 13.22.4. X-ray Crystallography 13.22.5. Others 13.23. Rest of Europe Biological Data Visualization Market Forecast, by Platform 13.23.1. Windows 13.23.2. Mac OS 13.23.3. Linux 13.23.4. Others 13.24. Rest of Europe Biological Data Visualization Market Forecast, by End User 13.24.1. Academic Research 13.24.2. Hospitals & Clinics 13.24.3. Pharmaceutical & Biotechnology Companies 13.24.4. Other Users 13.25. PEST Analysis 13.26. Key Trends 13.27. Key Developments 14. Asia-Pacific Biological Data Visualization Market Analysis 14.1. Key Findings 14.2. Asia-Pacific Biological Data Visualization Market Overview 14.3. Asia-Pacific Biological Data Visualization Market Forecast, by Technique 14.3.1. Microscopy 14.3.2. Magnetic Resonance Imaging 14.3.3. Sequencing 14.3.4. X-ray Crystallography 14.3.5. Others 14.4. Asia-Pacific Biological Data Visualization Market Forecast, by Platform 14.4.1. Windows 14.4.2. Mac OS 14.4.3. Linux 14.4.4. Others 14.5. Asia-Pacific Biological Data Visualization Market Forecast, by End User 14.5.1. Academic Research 14.5.2. Hospitals & Clinics 14.5.3. Pharmaceutical & Biotechnology Companies 14.5.4. Other Users 14.6. Asia-Pacific Biological Data Visualization Market Forecast, by Country 14.6.1. China 14.6.2. India 14.6.3. Japan 14.6.4. Malaysia 14.6.5. Indonesia 14.6.6. Rest of Asia-Pacific 14.7. China Biological Data Visualization Market Forecast, by Technique 14.7.1. Microscopy 14.7.2. Magnetic Resonance Imaging 14.7.3. Sequencing 14.7.4. X-ray Crystallography 14.7.5. Others 14.8. China Biological Data Visualization Market Forecast, by Platform 14.8.1. Windows 14.8.2. Mac OS 14.8.3. Linux 14.8.4. Others 14.9. China Biological Data Visualization Market Forecast, by End User 14.9.1. Academic Research 14.9.2. Hospitals & Clinics 14.9.3. Pharmaceutical & Biotechnology Companies 14.9.4. Other Users 14.10. India Biological Data Visualization Market Forecast, by Technique 14.10.1. Microscopy 14.10.2. Magnetic Resonance Imaging 14.10.3. Sequencing 14.10.4. X-ray Crystallography 14.10.5. Others 14.11. India Biological Data Visualization Market Forecast, by Platform 14.11.1. Windows 14.11.2. Mac OS 14.11.3. Linux 14.11.4. Others 14.12. India Biological Data Visualization Market Forecast, by End User 14.12.1. Academic Research 14.12.2. Hospitals & Clinics 14.12.3. Pharmaceutical & Biotechnology Companies 14.12.4. Other Users 14.13. Japan Biological Data Visualization Market Forecast, by Technique 14.13.1. Microscopy 14.13.2. Magnetic Resonance Imaging 14.13.3. Sequencing 14.13.4. X-ray Crystallography 14.13.5. Others 14.14. Japan Biological Data Visualization Market Forecast, by Platform 14.14.1. Windows 14.14.2. Mac OS 14.14.3. Linux 14.14.4. Others 14.15. Japan Biological Data Visualization Market Forecast, by End User 14.15.1. Academic Research 14.15.2. Hospitals & Clinics 14.15.3. Pharmaceutical & Biotechnology Companies 14.15.4. Other Users 14.16. Indonesia Biological Data Visualization Market Forecast, by Technique 14.16.1. Microscopy 14.16.2. Magnetic Resonance Imaging 14.16.3. Sequencing 14.16.4. X-ray Crystallography 14.16.5. Others 14.17. Indonesia Biological Data Visualization Market Forecast, by Platform 14.17.1. Windows 14.17.2. Mac OS 14.17.3. Linux 14.17.4. Others 14.18. Indonesia Biological Data Visualization Market Forecast, by End User 14.18.1. Academic Research 14.18.2. Hospitals & Clinics 14.18.3. Pharmaceutical & Biotechnology Companies 14.18.4. Other Users 14.19. Malaysia Biological Data Visualization Market Forecast, by Technique 14.19.1. Microscopy 14.19.2. Magnetic Resonance Imaging 14.19.3. Sequencing 14.19.4. X-ray Crystallography 14.19.5. Others 14.20. Malaysia Biological Data Visualization Market Forecast, by Platform 14.20.1. Windows 14.20.2. Mac OS 14.20.3. Linux 14.20.4. Others 14.21. Malaysia Biological Data Visualization Market Forecast, by End User 14.21.1. Academic Research 14.21.2. Hospitals & Clinics 14.21.3. Pharmaceutical & Biotechnology Companies 14.21.4. Other Users 14.22. Rest of Asia-Pacific Biological Data Visualization Market Forecast, by Technique 14.22.1. Microscopy 14.22.2. Magnetic Resonance Imaging 14.22.3. Sequencing 14.22.4. X-ray Crystallography 14.22.5. Others 14.23. Rest of Asia-Pacific Biological Data Visualization Market Forecast, by Platform 14.23.1. Windows 14.23.2. Mac OS 14.23.3. Linux 14.23.4. Others 14.24. Rest of Asia-Pacific Biological Data Visualization Market Forecast, by End User 14.24.1. Academic Research 14.24.2. Hospitals & Clinics 14.24.3. Pharmaceutical & Biotechnology Companies 14.24.4. Other Users 14.25. PEST Analysis 14.26. Key Trends 14.27. Key Developments 15. MEA & Africa Biological Data Visualization Market Analysis 15.1. Key Findings 15.2. MEA &Africa Biological Data Visualization Market Overview 15.3. MEA &Africa Biological Data Visualization Market Forecast, by Technique 15.3.1. Microscopy 15.3.2. Magnetic Resonance Imaging 15.3.3. Sequencing 15.3.4. X-ray Crystallography 15.3.5. Others 15.4. MEA &Africa Biological Data Visualization Market Forecast, by Platform 15.4.1. Windows 15.4.2. Mac OS 15.4.3. Linux 15.4.4. Others 15.5. MEA &Africa Biological Data Visualization Market Forecast, by End User 15.5.1. Academic Research 15.5.2. Hospitals & Clinics 15.5.3. Pharmaceutical & Biotechnology Companies 15.5.4. Other Users 15.6. MEA &Africa Biological Data Visualization Market Forecast, by Country 15.6.1. GCC 15.6.2. South Africa 15.6.3. Rest of MEA & Africa 15.7. GCC Biological Data Visualization Market Forecast, by Technique 15.7.1. Microscopy 15.7.2. Magnetic Resonance Imaging 15.7.3. Sequencing 15.7.4. X-ray Crystallography 15.7.5. Others 15.8. GCC Biological Data Visualization Market Forecast, by Platform 15.8.1. Windows 15.8.2. Mac OS 15.8.3. Linux 15.8.4. Others 15.9. GCC Biological Data Visualization Market Forecast, by End User 15.9.1. Academic Research 15.9.2. Hospitals & Clinics 15.9.3. Pharmaceutical & Biotechnology Companies 15.9.4. Other Users 15.10. South Africa Biological Data Visualization Market Forecast, by Technique 15.10.1. Microscopy 15.10.2. Magnetic Resonance Imaging 15.10.3. Sequencing 15.10.4. X-ray Crystallography 15.10.5. Others 15.11. South Africa Biological Data Visualization Market Forecast, by Platform 15.11.1. Windows 15.11.2. Mac OS 15.11.3. Linux 15.11.4. Others 15.12. South Africa Biological Data Visualization Market Forecast, by End User 15.12.1. Academic Research 15.12.2. Hospitals & Clinics 15.12.3. Pharmaceutical & Biotechnology Companies 15.12.4. Other Users 15.13. Rest of MEA &Africa Biological Data Visualization Market Forecast, by Technique 15.13.1. Microscopy 15.13.2. Magnetic Resonance Imaging 15.13.3. Sequencing 15.13.4. X-ray Crystallography 15.13.5. Others 15.14. Rest of MEA &Africa Biological Data Visualization Market Forecast, by Platform 15.14.1. Windows 15.14.2. Mac OS 15.14.3. Linux 15.14.4. Others 15.15. Rest of MEA &Africa Biological Data Visualization Market Forecast, by End User 15.15.1. Academic Research 15.15.2. Hospitals & Clinics 15.15.3. Pharmaceutical & Biotechnology Companies 15.15.4. Other Users 15.16. PEST Analysis 15.17. Key Trends 15.18. Key Developments 16. Latin America Biological Data Visualization Market Analysis 16.1. Key Findings 16.2. Latin America Biological Data Visualization Market Overview 16.3. Latin America Biological Data Visualization Market Forecast, by Technique 16.3.1. Microscopy 16.3.2. Magnetic Resonance Imaging 16.3.3. Sequencing 16.3.4. X-ray Crystallography 16.3.5. Others 16.4. Latin America Biological Data Visualization Market Forecast, by Platform 16.4.1. Windows 16.4.2. Mac OS 16.4.3. Linux 16.4.4. Others 16.5. Latin America Biological Data Visualization Market Forecast, by End User 16.5.1. Academic Research 16.5.2. Hospitals & Clinics 16.5.3. Pharmaceutical & Biotechnology Companies 16.5.4. Other Users 16.6. Latin America Biological Data Visualization Market Forecast, by Country 16.6.1. Mexico 16.6.2. Brazil 16.6.3. Rest of Latin America 16.7. Mexico Biological Data Visualization Market Forecast, by Technique 16.7.1. Microscopy 16.7.2. Magnetic Resonance Imaging 16.7.3. Sequencing 16.7.4. X-ray Crystallography 16.7.5. Others 16.8. Mexico Biological Data Visualization Market Forecast, by Platform 16.8.1. Windows 16.8.2. Mac OS 16.8.3. Linux 16.8.4. Others 16.9. Mexico Biological Data Visualization Market Forecast, by End User 16.9.1. Academic Research 16.9.2. Hospitals & Clinics 16.9.3. Pharmaceutical & Biotechnology Companies 16.9.4. Other Users 16.10. Brazil Biological Data Visualization Market Forecast, by Technique 16.10.1. Microscopy 16.10.2. Magnetic Resonance Imaging 16.10.3. Sequencing 16.10.4. X-ray Crystallography 16.10.5. Others 16.11. Brazil Biological Data Visualization Market Forecast, by Platform 16.11.1. Windows 16.11.2. Mac OS 16.11.3. Linux 16.11.4. Others 16.12. Brazil Biological Data Visualization Market Forecast, by End User 16.12.1. Academic Research 16.12.2. Hospitals & Clinics 16.12.3. Pharmaceutical & Biotechnology Companies 16.12.4. Other Users 16.13. Rest of Latin America Biological Data Visualization Market Forecast, by Technique 16.13.1. Microscopy 16.13.2. Magnetic Resonance Imaging 16.13.3. Sequencing 16.13.4. X-ray Crystallography 16.13.5. Others 16.14. Rest of Latin America Biological Data Visualization Market Forecast, by Platform 16.14.1. Windows 16.14.2. Mac OS 16.14.3. Linux 16.14.4. Others 16.15. Rest of Latin America Biological Data Visualization Market Forecast, by End User 16.15.1. Academic Research 16.15.2. Hospitals & Clinics 16.15.3. Pharmaceutical & Biotechnology Companies 16.15.4. Other Users 16.16. PEST Analysis 16.17. Key Trends 16.18. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Market Share Analysis, by Region 17.3. Market Share Analysis, by Country 17.4. Competition Matrix 17.4.1. Competitive Benchmarking of key players by price, presence, Market share, Raw material and R&D investment 17.4.2. New Raw material Launches and Raw material Enhancements 17.4.2.1. Market Consolidation 17.4.2.2. M&A by Regions, Investment and Raw material 17.4.2.3. M&A Key Players, Forward Integration and Backward Integration 17.5. Company Profiles: Key Players 17.5.1. Thermo Fisher Scientific Inc. 17.5.2. QIAGEN 17.5.3. Becton-Dickinson and Company 17.5.4. Agilent Technologies, Inc. 17.5.5. 3M 17.5.6. Carl Zeiss AG 17.5.7. Oxford Instruments 17.5.8. Olympus Corporation 17.5.9. GE Healthcare 17.5.10. Clarivate Analytics 17.5.11. arivis AG 17.5.12. Scientific Volume Imaging B.V. 17.5.13. Media Cybernetics, Inc. 17.5.14. Molecular Devices, LLC 17.5.15. Danaher. 18. Primary Key Insights.